A vaccine called GBP511 has begun clinical testing in Australia. Pioneered by UW Medicine researchers, it is intended to protect against COVID-19 and related coronaviruses — including some that haven’t yet jumped to humans. South Korean pharmaceutical company SK bioscience is bringing the vaccine to trial.